MEDP
Get informed when a big investor buys or sells
+ FollowUndervalued by 11.2% based on the discounted cash flow analysis.
| Market cap | $16.11 Billion |
|---|---|
| Enterprise Value | $16.63 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $15.64 |
| Beta | 1.15 |
| Outstanding Shares | 28,308,000 |
| P/E Ratio | 33.19 |
|---|---|
| PEG | 96.31 |
| Price to Sales | 5.87 |
| Price to Book Ratio | 38.34 |
| Enterprise Value to Revenue | 5.98 |
| Enterprise Value to EBIT | 28.58 |
| Enterprise Value to Net Income | 33 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 2.36 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 185.68% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 7.14%▼ 77.56% |
|---|---|
| Total Invested | $1.06B▼ 90.86% |
| Investors Holding | 235▼ 503.00% |
No data